HomePress-release

Redding, California - June 11, 2024

eClinical Solutions Market to be Worth $23.32 Billion by 2031

eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product (CDMS, CTMS, eCOA, ePRO, eDC, eTMF, Clinical Analytics, Safety Solutions), End User (Pharmaceutical, Clinical Research Organization, Medical Device), Phase – Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled, ‘eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product (CDMS, CTMS, eCOA, ePRO, eDC, eTMF, Clinical Analytics, Safety Solutions), End User (Pharmaceutical, Clinical Research Organization, Medical Device), Phase – Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the eClinical solutions market is projected to reach $23.32 billion by 2031, at a CAGR of 13.9% during the forecast period 2024–2031. The growth of the eClinical solutions market is primarily driven by the large amounts of data generated by the healthcare & life sciences industries, the growing number of clinical trials, initiatives supporting clinical research, and increasing funding for medical & pharmaceutical research & development. Moreover, IT infrastructure strengthening initiatives by large hospital chains, and the rising demand for precision medicine are expected to generate growth opportunities for the players operating in the eClinical solutions market.

Key Players

The key players operating in eClinical solutions market are Dassault Systems S.E. (France), Fountayn (U.S.), Merative L.P. (U.S.), eClinical Solutions LLC (U.S.), Clario (U.S.), eClinicalWorks, LLC (U.S.), IQVIA Inc. (U.S.), Parexel International (MA) Corporation (U.S.), MaxisIT Inc. (U.S.), Signant Health (U.S.), Castor (U.S.), Veeva Systems Inc. (U.S.), and Oracle Corporation (U.S.).

eClinical Solutions Market: Future Outlook

The eClinical solutions market is segmented by Product (Clinical Data Management Systems {CDMS}, Clinical Trial Management Systems {CTMS}, Randomization & Trial Supply Management Systems, Electronic Data Capture {EDC}, Electronic Clinical Outcome Assessments {eCOA}, Electronic Patient-reported Outcomes {ePRO}, Clinical Analytics Platforms, Electronic Trial Master File {eTMF}, Clinical Data Integration Platforms, Safety Solutions, and Other Product Types), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), End User (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Medical Device Manufacturers, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Based on product, the eClinical solutions market is segmented into clinical data management systems (CDMS), clinical trial management systems (CTMS), randomization & trial supply management systems, electronic data capture (EDC), electronic clinical outcome assessments (eCOA), electronic patient-reported outcomes (ePRO), clinical analytics platforms, electronic trial master file (ETMF), clinical data integration platforms, safety solutions, and other product types, the clinical trial management systems (CTMS) segment is projected to register the highest growth rate of 13.5% during the forecast period 2024–2031. The segment’s growth is driven by the increase in clinical research and clinical trials, the growing demand for organized clinical trial data, and the shift toward decentralized clinical trials. CTMS plays a crucial role in the success and reliability of clinical trials. It ensures the quality, accuracy, and integrity of clinical data, which is essential to evaluate the safety and efficacy of medication.

Based on end user, the eClinical solutions market is segmented into pharmaceutical & biopharmaceutical companies, clinical research organizations, medical device manufacturers, and other end users. In 2024, the pharmaceutical & biopharmaceutical companies segment is expected to account for the largest share of the eClinical solutions market. The large share of this segment is attributed to the large number of clinical trials being undertaken and the high focus of pharmaceutical and biopharmaceutical companies on accelerating drug research & development and securing drug approvals. For instance, in 2023, 55 novel drugs were approved by the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) compared to 37 novel drugs in 2022.

This research report analyzes major geographies and provides a comprehensive analysis of the eClinical solutions market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Sweden, Netherlands, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.

Based on geography, Asia-Pacific is projected to register the highest CAGR during the forecast period. India and China offer lucrative opportunities for the players operating in the eClinical solutions market due to the growing pharmaceutical & biopharmaceutical industries, high number of clinical trials, increased preference for eClinical solutions over manual data management and data entry procedures, and rising investments in pharmaceutical R&D. For instance, in 2021-22 the Foreign Direct Investment (FDI) in India for drugs & pharmaceutical activities accounted for $1,344.1 million (Source: Ministry of Chemicals & Fertilizers, Government of India).

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5910

Key Questions Answered in the Report:

What is the revenue generated from the sale of eClinical solutions across the globe?
At what rate is the demand for eClinical solutions projected to grow for the next 5-7 years?
What is the historical market size and growth rate for eClinical solutions across the globe?
What are the major factors impacting the growth of this market at the regional level? What are the major opportunities for existing market players and new entrants in the market?
Which segments are creating major traction for the vendors in this market in terms of product, clinical trial phase, and end user?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the eClinical solutions market?
Who are the major players in the eClinical solutions market? What are their offerings?
What are the recent key developments in the eClinical solutions market, and what are the impacts of these developments?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - June 11, 2024

eClinical Solutions Market to be Worth $23.32 Billion by 2031

eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product (CDMS, CTMS, eCOA, ePRO, eDC, eTMF, Clinical Analytics, Safety Solutions), End User (Pharmaceutical, Clinical Research Organization, Medical Device), Phase – Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies